drugset
drugset / Trial / NCT07502651

a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture

NCT07502651 ↗

Phase 0 Enrolling by invitation 32 enrolled Postgraduate Institute of Dental Sciences Rohtak
RandomizedParallel-groupDouble-blindTreatment

Summary

COMPARISON OF THE EFFICACY OF INTRANASAL MIDAZOLAM AND DEXMEDETOMIDINE AS A SEDATIVE AGENT IN SURGICAL MANAGEMENT OF ISOLATED MANDIBLE FRACTURE- conducted on 32 subject to assess depth of sedation by using OAA/S and assess effect on bp and heart rate

Timeline

Start
2025-05-25
Primary completion
2027-03-31
Completion
2027-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — Intranasal
Comparator Midazolam Small molecule — Intranasal

Indications

No indication recorded.